Jun localization in cytosolic and nuclear compartments in brain-pituitary system of the frog, Rana esculenta: an analysis carried out in parallel with GnRH molecular forms during the annual reproductive cycle.
The presence of c-jun like mRNA was assessed in the brain of the frog, Rana esculenta, during the annual sexual cycle. In parallel, Jun protein and GnRH molecular form (mammalian and chicken II also indicated as GnRH1 and GnRH2, respectively) activity was studied in order to establish possible relationships. Northern blot analysis of total RNA reveals the presence of a 2.7 kb c-jun-like mRNA. Western blots, carried out on cytoplasmic and nuclear protein extracts, show the presence of Jun immunoreactive band of 39 kDa in brain and pituitary. Fluctuations of c-jun-like mRNA and Jun immunoreactive protein (cytoplasmic and nuclear) levels in brains during the year indicate relationships among transcription, translation, and nuclear activity. In particular, mRNA levels increase gradually from September until November when Jun protein concentration peaks in cytosolic extracts. Conversely, the nuclear protein reaches highest concentration in July when the cytosolic level shows low values. Immunocytochemical studies confirm the presence of Jun immunoreactivity in both cytoplasmic and nuclear compartments of several brain areas, including those primarily involved in gonadotropin discharge (e.g., anterior preoptic area and preoptic nucleus). GnRH molecular forms and Jun are colocalized in anterior preoptic area and preoptic nucleus. Moreover, during the period characterized by GnRH release, Jun levels strongly decrease in nuclei. Finally, we show that treatments with a GnRH analog (buserelin, Hoechst, Frankfurt) increase Jun levels in brain nuclear extracts.
Meccariello
R
R
Dipartimento di Medicina Sperimentale, II Università di Napoli, Via Costantinopoli 16, 80138, Italy.
Mathieu
M
M
Cobellis
G
G
Vallarino
M
M
Bruzzone
F
F
Fienga
G
G
Pierantoni
R
R
Fasano
S
S
D000818:Animals; D015152:Blotting, Northern; D015153:Blotting, Western; D001921:Brain / Q000033:anatomy & histology / Q000166:cytology / Q000378:metabolism*; D001923:Brain Chemistry; D002467:Cell Nucleus / Q000737:chemistry / Q000378:metabolism; D003593:Cytoplasm / Q000737:chemistry / Q000378:metabolism; D003600:Cytosol / Q000737:chemistry; D015870:Gene Expression / Q000187:drug effects; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists / Q000031:analogs & derivatives* / Q000032:analysis / Q000037:antagonists & inhibitors / Q000378:metabolism* / Q000494:pharmacology; D007150:Immunohistochemistry; D008297:Male; D009474:Neurons / Q000737:chemistry / Q000378:metabolism; D010902:Pituitary Gland / Q000033:anatomy & histology / Q000166:cytology / Q000378:metabolism*; D011301:Preoptic Area / Q000033:anatomy & histology / Q000166:cytology / Q000378:metabolism; D016755:Proto-Oncogene Proteins c-jun / Q000032:analysis / Q000235:genetics / Q000378:metabolism*; D011761:Pyrrolidonecarboxylic Acid / Q000031:analogs & derivatives; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D011893:Rana esculenta; D012098:Reproduction / Q000502:physiology; D012621:Seasons
D016755:Proto-Oncogene Proteins c-jun; D012333:RNA, Messenger; D007987:Gonadotropin-Releasing Hormone; C037700:LHRH, Gln(8)-; C034511:LHRH, pGlu(1)-Phe(2)-Trp(3,6)-; C083781:LHRH, Ala(6)-Gly(10)-ethylamide-; C047717:LHRH, His(5)-Trp(7)-Tyr(8)-; D011761:Pyrrolidonecarboxylic Acid